Antibodies Against Human CSF-1R and Uses Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 12/962,445, filed Dec 7, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,499,625 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | ||
| US 9,499,626 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | ||
| US 9,663,580 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | ||
| US 9,879,085 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | ||
| US 10,072,087 | Antibodies Against Human CSF-1R and Uses Thereof In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | ||
| US 10,077,314 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | ||
| US 10,287,358 | Antibodies Against Human CSF-1R and Uses Thereof In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | ||
| US 9,499,624 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | ||
| US 8,999,327 | Antibodies Against Human CSF-1R and Uses Thereof In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | ||
| Application 16/362,962 | Antibodies Against Human CSF-1R and Uses Thereof Abandoned Abandoned Feb 1, 2020 | Hoffmann-La Roche Inc. | Abandoned | Abandoned Feb 1, 2020 |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
9 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.